About Apostle
Apostle is a Healthcare company based in Sunnyvale (United States) founded in 2017. It operates as an AI-enabled nanotechnology is utilized for early cancer detection. It operates in the Healthcare and Technology sectors. Apostle has raised $5.63 million across 2 funding rounds from investors including Amino Capital, ShangBay Capital and Westlake Ventures. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
Apostle was founded in 2017 and is headquartered in Sunnyvale, United States. Operations are centered in the biotechnology sector, where nanoparticles featuring varied material compositions, surface chemistries, large surface areas, and low variation are developed to isolate circulating tumor DNA from other genetic material. An AI-integrated system, known as AI-enabled nanoDiagnostics (AID) technology, is employed to support these processes.
- Headquarters Sunnyvale, United States
- SectorsHealthcareTechnology
- Email••••••••
- Website apostlebio.com
- Social LinkedIn X
- Total Equity Funding$5.63M (USD)
in 2 rounds
- Latest Funding Round$3.33M (USD), Series A
Jun 2019
- InvestorsAmino Capital
& 2 more
Funding Insights of Apostle
Apostle has successfully raised a total of $5.63M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.33 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.63M
- Total Rounds 2
- Last Round Series A — $3.33M
- First Round $2.3M
(Jun 2017)
- Investors Count 3
All 2 funding rounds of Apostle with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $3.33M | Series A | – | – | – |
| Jun 2017 | $2.3M | Seed | – | Amino Capital, ShangBay Capital | – |
3 investors in total: 3 institutional.
Investors in Apostle
Apostle has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Amino Capital, ShangBay Capital and Westlake Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech investments are targeted in US, China, and Europe. | – | aminocapital.com | Palo Alto, United States | |
- | – | shangbaycapital.com | - | |
Westlake Ventures is focused on investing in innovative companies. | – | westlakeventures.net | St. Petersburg, United States |
Investor details for Apostle
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Apostle
14 people are tracked at Apostle (7 in leadership, 7 in board & advisors).
| Name | Role | Group |
|---|---|---|
David Ge | CEO & President | Leadership |
Eric D. Masingale | VP, Business Ops | Leadership |
Xin Guo | VP, Bioinformatics | Leadership |
Wenqi Zeng | SVP, Medicine & Lab Director | Leadership |
Charles Strom | Lab Co-Director | Leadership |
Bo Zhang | VP, Chemistry | Leadership |
Wenqi (Wayne) Zeng MD, PhD | Co-founder & Senior VP | Leadership |
David B. Goldstein | Scientific Advisor | Board & advisors |
Alexander J. Hartemink | Scientific Advisor | Board & advisors |
Hongyu Zhao | Scientific Advisor | Board & advisors |
John Mchutchison | Scientific Advisor | Board & advisors |
Charles Cantor | Scientific Advisor | Board & advisors |
Dean Felsher | Scientific Advisor | Board & advisors |
Xiang Qian | Scientific Advisor | Board & advisors |
Complete people profiles for Apostle
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Apostle
3 dated milestones of Apostle across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Apostle is founded.
- Funding First funding round of $2.3M.
- Funding Latest funding round, Series A, of $3.3M.
Competitors of Apostle
Apostle has 9 listed competitors in our database, 9 of them funded. They include Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| veracyte.com | 2008 | San Francisco, United States | $67.9M | 815 | Genomics-based diagnostic tests for cancer are developed. | |
| thrivedetect.com | 2019 | Cambridge, United States | $367M | 138 | Blood-based liquid biopsy tests for multiple cancer detection are provided. | |
| delfidiagnostics.com | 2019 | Baltimore, United States | $331.59M | – | Provider of DNA sequencing for cancer detection |
Detailed competitors of Apostle
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Apostle
The website of Apostle (apostlebio.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 1.1% vs previous month
Websites whose visitors overlap most with Apostle. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| peridotcorp.com | 100% | 1.4K | #10,480,082 | View details | |
| sfj-pharma.com | 100% | 2K | #10,295,139 | View details | |
| conxtech.com | 100% | 3.2K | #5,353,487 | View details | |
proformaco.com | proformaco.com | 99% | – | #8,335,573 | – |
matchps.com | matchps.com | 99% | – | #3,460,996 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Apostle
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Apostle (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apostle
Apostle was founded in 2017.
Apostle is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Apostle is a funded company, having raised a total of $5.63M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.3M, raised on Jun 2017.
Apostle was founded in 2017 and is headquartered in Sunnyvale, United States. Operations are centered in the biotechnology sector, where nanoparticles featuring varied material compositions, surface chemistries, large surface areas, and low variation are developed to isolate circulating tumor DNA from other genetic material. An AI-integrated system, known as AI-enabled nanoDiagnostics (AID) technology, is employed to support these processes.
Apostle's top competitors include Guardant Health, Foundation Medicine and Natera.
Apostle has 3 investors. Key investors include Amino Capital, ShangBay Capital, and Westlake Ventures.